Battle Royale – Freestyle Libre 3 and Dexcom G7 face off – The results | Diabettech – Diabetes and Technology

Combined Consensus Error Grid As previously discussed in this article, I have been wearing the Libre 3, Dexcom G6 and G7, to compare performance across all three.  These are the results. These are laid out showing the Consensus Error Grid for each device and all three together followed by tables providing data about the BIAS, … Read more

The art of CGM accuracy studies, part 2: The Freestyle Libre3 | Diabettech – Diabetes and Technology

As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, I thought it worth while in taking a quick look at the Libre3, and it’s much vaunted accuracy data. “But that’s quite a cynical title”, you might be saying to … Read more

Battle Royale… The Dexcom G7 takes on the Freestyle Libre3 | Diabettech – Diabetes and Technology

It’s finally here. The Dexcom G7 has landed. And now it’s time for us here at Diabettech to pitch it against Abbott’s Freestyle Libre 3. Both these devices have been circulating for some time, amid mounting excitement amongst a reasonable portion of the diabetes community, as published data suggests a better user experience. We’ll be … Read more

Dexcom One. Forcing Abbott to make Libre 2 truly a realtime CGM? | Diabettech – Diabetes and Technology

Six months ago now, NICE launched the updated NG17 guidelines for adults with type 1 diabetes that contained the details of CGM for all users. Over the course of the next six months, multiple vendors launched cut price CGM systems that were acceptable to the NHS Business Services Authority and wound their way onto the … Read more

How to get real time CGM on prescription in England. A brief approach… | Diabettech – Diabetes and Technology

There’s a lot of discussion around the new rtCGMs being available on prescription, but local GPs saying that they aren’t or telling you there’s nothing they can do. Most people with diabetes have a reasonably good relationship with their GP, and therefore should be able to have a conversation on a reasonable level regarding the … Read more

Keep on movin’…. Factoring variation in activity into open source AID systems | Diabettech – Diabetes and Technology

With the past 18 months or working on Boost and using it, various patterns have shown their heads. In the past I’ve written about the “hangover” effects of weight training and insulin sensitivity, and this past summer of participating in the 1mn steps challenge has provided an alternative view of how insulin sensitivity works in … Read more

Accessing Real Time CGM in London. The unfair fairground? | Diabettech – Diabetes and Technology

London. A city of 10 million people, 32 boroughs, five Integrated care systems (ICS), and probably 66,000 people with type 1 diabetes. London. Also a city with a Diabetes Clinical Network and a procurement partnership. Two NHS meta-organisations designed to improve collaboration across boroughs and ICSs. NICE guidelines that say that anyone with type 1 … Read more

Non-invasive CGM. Coming soon, apparently… | Diabettech – Diabetes and Technology

If you’re on Social Media, and follow diabetes, you can’t fail to have seen the noise from GlucoRX and the JDRF about BioXensor, a new, non-invasive Continuous Glucose Monitor (NICGM). While there’re plenty of exciting soundbytes relating to this brand new products, as is often the case with NICGM, there’s not a lot of detail. … Read more

Comparing Dexcom’s One with Libre2 | Diabettech – Diabetes and Technology

Comparing Dexcom’s One with Libre2 Having had the Libre2 fall off during the first few hours of the “Six of the Best” test, I decided to run One Vs Libre2 (the two cost neutral options on the NHS Drug Tariff) head to head against one another. In this case, I used the Librelink software to … Read more